Literature DB >> 10639010

Thienopyridines: effects on cultured endothelial cells.

B Ziemianin1, R Olszanecki, W Uracz, E Marcinkiewicz, R J Gryglewski.   

Abstract

In cultured endothelial cells harvested from human umbilical vein (HUVEC) or bovine aorta (BAEC) the 30 min incubation with calcium ionophore A 23187 (1 microM) or ticlopidine (100 microM) caused an increase in nitrite generation in HUVEC from basal 227 +/- 37 to 372 +/- 60 or to 325 +/- 33 pmoles per 10(6) cells, respectively, and in BAEC from basal 182 +/- 17 to 378 +/- 18 or to 423 +/- 66 pmoles per 106 cells (n = 6), respectively. Calcium ionophore A 23187 (1 microM) or ticlopidine (100 microM) next to 30 min incubation with BAEC increased release of 6-keto-PGF 1alpha from basal level of 9.4 +/- 1.8 to 96.2 +/- 5.1 or to 99.5 +/- 10.2 pmoles per 10(6) cells, respectively. The pretreatment with aspirin (300 microM) cut down this rise to 4.2 +/- 0.1 pmoles per 10(6) cells (n = 8). Basal cytoplasmic calcium levels, [Ca2+]i, in immortalised HUVEC cell line - ECV304, HUVEC and BAEC were 47.7 +/- 3.3 nM (n = 53), 68.3 +/- 5.0 nM (n = 30) and 53.1 +/- 3.0 nM (n = 15), respectively. In these cultured endothelial cells calcium ionophore A 23187 (0.1 microM) produced net maximum rise in [Ca2+]i by 157 +/-27 nM (n = 16)[ ECV304], by 107 +/- 58 nM (n=4) [HUVEC], and by 231.0 +/- 41.3 nM (n = 8) [BAEC], respectively, while ticlopidine (30 microM) produced net maximum rise in [Ca2+]i by 30.0 +/- 3.2 nM (n=9)[ECV304], 48.8 +/- 15.6 nM (n = 4)[HUVEC] and 28.4 +/- 5.4 nM (n = 8)[BAEC], respectively. Effect of ticlopidine on [Ca2+]i was not only weaker than that of calcium A 23187 but also its maximum appeared after a lag period that was 2 3 times longer than that for A23187. In ECV304 clopidogrel at concentrations of 10, 30 and 100 microM produced maximum increment of [Ca2+]i by 16.5 +/- 3.8 nM (n = 7), 47.0 +/- 6.9 nM (n = 8) and 67.2 +/- 8.3 nM (n = 8), respectively. Incubation of BAEC with A23187 (microM), ticlopidine or clopidogrel (100 microM) for 2 h did not influence viability of cultured endothelial cells. We claim that thienopyridines, independently of their delayed anti-platelet properties ex vivo do release NO and PGI2 from cultured endothelial cells in vitro. The above endothelial action of thienopyridines might be mediated by a rise in [Ca2+]i, however, this possibility has not been proved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10639010

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

1.  Unusual effects of aspirin on ticlopidine induced thrombolysis.

Authors:  R J Gryglewski; W Uracz; J Swieş
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Usefulness of clopidogrel to protect against diabetes-induced vascular damage.

Authors:  John A McClung; Adam L Kruger; Ambra Ferraris; Luca Vanella; Petr Tsenovoy; Melvin B Weiss; Nader G Abraham
Journal:  Am J Cardiol       Date:  2010-04-01       Impact factor: 2.778

Review 3.  Clinical implications of platelet-vessel interaction.

Authors:  Fabio Mangiacapra; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2012-12-28       Impact factor: 4.132

4.  Effects of thienopyridines and thienopyrimidinones on L-type calcium current in isolated cardiomyocytes.

Authors:  Brigitte Pelzmann; Klaus Zorn-Pauly; Seth Hallström; Heinrich Mächler; Andrzej Jakubowski; Petra Lang; Bernd Koidl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-14       Impact factor: 3.000

5.  Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel.

Authors:  Michalis Hamilos; Olivier Muller; Argyrios Ntalianis; Catalina Trana; Jozef Bartunek; Giovanna Sarno; Fabio Mangiacapra; Karen Dierickx; Peter Meeus; Thomas Cuisset; Bernard De Bruyne; William Wijns; Emanuele Barbato
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

Review 6.  Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).

Authors:  Anaadriana Zakarija; Hau C Kwaan; Joel L Moake; Nicholas Bandarenko; Dilip K Pandey; June M McKoy; Paul R Yarnold; Dennis W Raisch; Jeffrey L Winters; Thomas J Raife; John F Cursio; Thanh Ha Luu; Elizabeth A Richey; Matthew J Fisher; Thomas L Ortel; Martin S Tallman; X Long Zheng; Masanori Matsumoto; Yoshihiro Fujimura; Charles L Bennett
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

7.  Comparison of the influence of ticagrelor and clopidogrel on inflammatory biomarkers and vascular endothelial function for patients with ST-segment elevation myocardial infarction receiving emergency percutaneous coronary intervention: study protocol for a randomized controlled trial.

Authors:  Zhenhua Li; Yueyan Li; Tao Zhang; Wei Miao; Guohai Su
Journal:  Trials       Date:  2016-02-11       Impact factor: 2.279

8.  P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.

Authors:  Feng Jing; Yixin Zhang; Ting Long; Wei He; Guangcheng Qin; Dunke Zhang; Lixue Chen; Jiying Zhou
Journal:  J Neuroinflammation       Date:  2019-11-13       Impact factor: 8.322

9.  Clopidogrel Protects Endothelium by Hindering TNFα-Induced VCAM-1 Expression through CaMKKβ/AMPK/Nrf2 Pathway.

Authors:  Huabing Yang; Pengjun Zhao; Shiliu Tian
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.